Histopathological characteristics of patients with thyroid nodules according to the Bethesda classification

The Bethesda Classification for Reporting Thyroid Cytopathology (BSRTC) was developed in 2010 to provide a standardized framework for interpreting and reporting FNA cytology, and its use is recommended for the evaluation of thyroid nodules in both adults and children. Research methodology: A retrospective analysis of 51 patients with thyroid nodules was performed. Of the 51patients, 33 were men and 18 were women. Research results. The majority of patients, a total of 35 out of 51 patients, belonged to Bethesda category II (72.5%), while 2 were category I (3.9%), 7 were category III (13.7%), 2 were category IV (3.9 %), 3 - category V (5.9%) and 1 patient belonged to category VI (1.9%), respectively. 2 patients with Bethesda category I underwent repeat FNA, and later they had category II. When analyzing the cytological response, the Bethesda classification must be used for proper prognosis and treatment.